Johansen Maja L, Bak Lasse K, Schousboe Arne, Iversen Peter, Sørensen Michael, Keiding Susanne, Vilstrup Hendrik, Gjedde Albert, Ott Peter, Waagepetersen Helle S
Department of Pharmacology and Pharmacotherapy, Faculty of Pharmaceutical Sciences, University of Copenhagen, 2 Universitetsparken, 2100 Copenhagen, Denmark.
Neurochem Int. 2007 Jun;50(7-8):1042-51. doi: 10.1016/j.neuint.2007.01.009. Epub 2007 Feb 6.
Cerebral hyperammonemia is a hallmark of hepatic encephalopathy, a debilitating condition arising secondary to liver disease. Pyruvate oxidation including tricarboxylic acid (TCA) cycle metabolism has been suggested to be inhibited by hyperammonemia at the pyruvate and alpha-ketoglutarate dehydrogenase steps. Catabolism of the branched-chain amino acid isoleucine provides both acetyl-CoA and succinyl-CoA, thus by-passing both the pyruvate dehydrogenase and the alpha-ketoglutarate dehydrogenase steps. Potentially, this will enable the TCA cycle to work in the face of ammonium-induced inhibition. In addition, this will provide the alpha-ketoglutarate carbon skeleton for glutamate and glutamine synthesis by glutamate dehydrogenase and glutamine synthetase (astrocytes only), respectively, both reactions fixing ammonium. Cultured cerebellar neurons (primarily glutamatergic) or astrocytes were incubated in the presence of either [U-13C]glucose (2.5 mM) and isoleucine (1 mM) or [U-13C]isoleucine and glucose. Cell cultures were treated with an acute ammonium chloride load of 2 (astrocytes) or 5 mM (neurons and astrocytes) and incorporation of 13C-label into glutamate, aspartate, glutamine and alanine was determined employing mass spectrometry. Labeling from [U-13C]glucose in glutamate and aspartate increased as a result of ammonium-treatment in both neurons and astrocytes, suggesting that the TCA cycle was not inhibited. Labeling in alanine increased in neurons but not in astrocytes, indicating elevated glycolysis in neurons. For both neurons and astrocytes, labeling from [U-13C]isoleucine entered glutamate and aspartate albeit to a lower extent than from [U-13C]glucose. Labeling in glutamate and aspartate from [U-13C]isoleucine was decreased by ammonium treatment in neurons but not in astrocytes, the former probably reflecting increased metabolism of unlabeled glucose. In astrocytes, ammonia treatment resulted in glutamine production and release to the medium, partially supported by catabolism of [U-13C]isoleucine. In conclusion, i) neuronal and astrocytic TCA cycle metabolism was not inhibited by ammonium and ii) isoleucine may provide the carbon skeleton for synthesis of glutamate/glutamine in the detoxification of ammonium.
脑内高氨血症是肝性脑病的一个标志,肝性脑病是一种继发于肝脏疾病的使人衰弱的病症。丙酮酸氧化包括三羧酸(TCA)循环代谢,已有人提出在丙酮酸和α-酮戊二酸脱氢酶步骤中,高氨血症会抑制该过程。支链氨基酸异亮氨酸的分解代谢可提供乙酰辅酶A和琥珀酰辅酶A,从而绕过丙酮酸脱氢酶和α-酮戊二酸脱氢酶步骤。这有可能使TCA循环在铵诱导的抑制作用下仍能发挥作用。此外,这将分别为谷氨酸脱氢酶和谷氨酰胺合成酶(仅星形胶质细胞)合成谷氨酸和谷氨酰胺提供α-酮戊二酸碳骨架,这两个反应都能固定铵。将培养的小脑神经元(主要是谷氨酸能神经元)或星形胶质细胞置于[U-13C]葡萄糖(2.5 mM)和异亮氨酸(1 mM)或[U-13C]异亮氨酸和葡萄糖存在的环境中进行孵育。细胞培养物用2 mM(星形胶质细胞)或5 mM(神经元和星形胶质细胞)的急性氯化铵负荷进行处理,并采用质谱法测定13C标记掺入谷氨酸、天冬氨酸、谷氨酰胺和丙氨酸的情况。在神经元和星形胶质细胞中,由于铵处理,[U-13C]葡萄糖在谷氨酸和天冬氨酸中的标记增加,这表明TCA循环未受抑制。丙氨酸中的标记在神经元中增加,但在星形胶质细胞中未增加,这表明神经元中的糖酵解增强。对于神经元和星形胶质细胞,[U-13C]异亮氨酸的标记进入了谷氨酸和天冬氨酸,尽管程度低于[U-13C]葡萄糖。在神经元中,铵处理使[U-13C]异亮氨酸在谷氨酸和天冬氨酸中的标记减少,但在星形胶质细胞中未减少,前者可能反映了未标记葡萄糖代谢的增加。在星形胶质细胞中,氨处理导致谷氨酰胺的产生并释放到培养基中,[U-13C]异亮氨酸的分解代谢部分支持了这一过程。总之,i)铵不会抑制神经元和星形胶质细胞的TCA循环代谢,ii)在铵解毒过程中,异亮氨酸可能为谷氨酸/谷氨酰胺的合成提供碳骨架。